Launches, approvals, and release dates: markets where the base rate of delay is the most valuable number on the page.
The honest overview
Science and tech markets settle on discrete announced events: a rocket launching by a date, a regulatory approval landing, a product or model shipping, a mission milestone. They attract optimists, because the people drawn to these markets love the technology, and optimism has a price. That price is systematically too high on 'it happens on schedule'.
The single most transferable insight in this category: announced dates for complex engineering slip as a rule, not an exception. The informed side of these markets is not smarter about the technology; it is calibrated about delay. Whoever holds the honest base rate for slippage in the relevant domain owns the category.
How these markets actually work
The settlement wording carries everything: launched versus attempted, approved versus advisory-committee-recommended, released versus announced, generally available versus waitlisted. Two markets on the same headline event settle opposite ways on these words, and the rules define each one.
Deadline markets ('by December 31') are bets on schedules, and schedules for novel engineering are systematically optimistic. Weather scrubs, regulatory paperwork, supply chains, and safety reviews all push one direction: later.
Some events resolve on official sources with lag (agency publications, company confirmations). Livestream evidence and official settlement can differ by hours or days, and the rules name which counts.
Where real edges come from
Price the delay base rate, not the press release. For date markets, the question is never whether the thing will happen; it is the historical distribution of slippage for this kind of thing, this organization, this stage of development. Enthusiast money prices the announcement; calibrated money prices the distribution.
Regulatory calendars are public machinery: decision deadlines, committee meeting dates, and statutory clocks are published. Markets keyed to them reprice on knowable dates, and the reprice around a scheduled decision window is tradable structure, not speculation.
Domain reading pays asymmetrically here. A market on a technical milestone is often priced by people who read the headline; the person who read the filing, the environmental review, or the test campaign's actual progression holds a real informational edge, one of the few honest ones retail can still earn.
Red flags
Conditions where the trade is usually worse than it looks. Any one of these firing is a reason to pass.
🚩 Buying the announced date
The announced schedule is the optimistic bound, published by the party with every incentive to sound on-track. Paying a price that implies the announced date is likely is paying retail for optimism.
🚩 Fandom is your thesis
Loving the company, the founder, or the mission is the same bias as betting your team in primetime. The markets most polluted by enthusiasm are exactly the ones where fading it has historically paid, uncomfortably.
🚩 Trading the binary read without the domain
Approval decisions and technical milestones hinge on documents specialists actually read. If your information diet is headlines and the other side's is filings, you are the liquidity.
🚩 Settlement-word skimming
'Launches by' versus 'attempts by', 'released' versus 'announced': these markets are famous for settling against people who traded the headline instead of the wording.
Orange flags
Proceed only after you have checked the specific thing named.
⚠ Definition of done for software and AI markets
What counts as a model or product being 'released' (public access, paid tiers, regional availability) is defined in the rules and disputed everywhere else. Read it before trading anything about a release.
⚠ Single-source confirmation lag
If settlement waits on an official publication, expect the market to sit resolved-in-fact but unsettled-in-form. Capital lock is part of the price.
Green lights
The conditions under which taking the trade is actually defensible.
✓ You priced the slippage distribution
You looked at how similar timelines have actually slipped historically and your position reflects that distribution, especially when it lets you sell the optimism premium rather than pay it.
✓ You read the primary document
The filing, the review, the test-campaign log: your edge is that you read what the headline summarized, and the price still reflects only the headline.
✓ A scheduled decision window anchors it
The market resolves against a published regulatory or procedural date, and your position is about the decision's distribution, placed before the window's chaos.
Because announced dates for complex engineering are systematically optimistic, and the buyers of YES are pricing the press release rather than the historical distribution of delays. The pattern is stable enough that the delay base rate, not technical insight, is the category's core number.
How do AI and product release markets settle?
On the precise definition in the rules: what counts as released, to whom, and confirmed by which source. General availability, limited access, and announcements are different events, and the wording decides which one you actually traded.
Field guides are educational and describe historical patterns and mechanics; nothing here is a recommendation to trade any market. Rules quoted generically; the specific market’s rules page always governs. Not financial advice.